Development of an ectopic huLiver model for Plasmodium liver stage infection.

Saved in:
Bibliographic Details
Title: Development of an ectopic huLiver model for Plasmodium liver stage infection.
Authors: Samayoa-Reyes G; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America., Flaherty SM; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America., Wickham KS; Department of Drug Discovery, Experimental Therapeutics Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America., Viera-Morilla S; Diseases of the Developing World, Infectious Diseases-Centre for Excellence in Drug Discovery (ID CEDD), GlaxoSmithKline, Tres Cantos, Madrid, Spain., Strauch PM; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America., Roth A; Department of Drug Discovery, Experimental Therapeutics Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America., Padrón L; Diseases of the Developing World, Infectious Diseases-Centre for Excellence in Drug Discovery (ID CEDD), GlaxoSmithKline, Tres Cantos, Madrid, Spain., Jackson CM; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America., Meireles P; Diseases of the Developing World, Infectious Diseases-Centre for Excellence in Drug Discovery (ID CEDD), GlaxoSmithKline, Tres Cantos, Madrid, Spain., Calvo D; Diseases of the Developing World, Infectious Diseases-Centre for Excellence in Drug Discovery (ID CEDD), GlaxoSmithKline, Tres Cantos, Madrid, Spain., Roobsoong W; Faculty of Tropical Medicine, Mahidol Vivax Research Unit, Mahidol University, Bangkok, Thailand., Kangwanrangsan N; Faculty of Science, Pathobiology Department, Mahidol University, Bangkok, Thailand., Sattabongkot J; Faculty of Tropical Medicine, Mahidol Vivax Research Unit, Mahidol University, Bangkok, Thailand., Reichard G; Department of Drug Discovery, Experimental Therapeutics Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America., Lafuente-Monasterio MJ; Diseases of the Developing World, Infectious Diseases-Centre for Excellence in Drug Discovery (ID CEDD), GlaxoSmithKline, Tres Cantos, Madrid, Spain., Rochford R; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
Source: PloS one [PLoS One] 2023 Mar 16; Vol. 18 (3), pp. e0279144. Date of Electronic Publication: 2023 Mar 16 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0279144